Free Newsletter
Mice burn off fat after scientists delete a gene
Deleting the IKKE gene from mice allowed the animals to eat a diet rich in lard without gaining weight. And the researchers say the same approach has the potential to control weight in humans.
"We've studied other genes associated with obesity--we call them 'obesogenes'--but this is the first one we've found that, when deleted, stops the animal from gaining weight," senior study author Alan Saltiel, the Mary Sue Coleman Director of the University of Michigan Life Sciences Institute, said in a university news release.
Eliminating the IKKE gene apparently works by speeding the metabolism of mice, spurring them to burn more calories. "The knockout mice are not exercising any more than the control mice used in the study. They're just burning more energy," Saltiel said. "And in the process, they're generating a little heat, as well--their body temperature actually increases a bit."
- read the story from HealthDay News
Related Articles:
Genetic breakthrough offers new target for obesity, diabetes
'Obesity gene' could be key to new therapy
Scripps Research team finds new obesity target
Genetic tinkering creates obesity-resistant mice
More stories about obesity
Comments
By Bobcat | Posted 2:37pm | September 9, 2009
I have a concern regarding, the extraction of the codone plus one IKKE: Firstly, fat globules are excellent for the body. However, not in extreme amounts. Adipose tissue serves as a cusion and o is, enmeshed in our integumentary system. I believe that fat deposits also make collagen and fibrinogen; which restores cellular structure.
If we continue to state fat is bad for the obese. Then we send the wrong message to the slender citizens. Suppose, all obese citizens can achieve slender sleek bodies after this new alleged treatment.
What happens to his or her sugar level?
What happens to his or her salt levels and electrolyte balance?
Does the client become dehydrated or hyperhydrated and needs other medical attentions, to be implemented?
I guess what I am saying is, we need medications which serve the one, two punch a multitasking medication. For instance, a pill which can reduce the level of pain, assisting reducing constipation, and maintain the intestinal ph. A medication that buffers.
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: